{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:06:35Z","timestamp":1777608395266,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11033-020-06014-0","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T14:07:59Z","timestamp":1606226879000},"page":"9279-9288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cascade screening and genetic diagnosis of familial hypercholesterolemia in clusters of the Southeastern region from Brazil"],"prefix":"10.1007","volume":"47","author":[{"given":"J\u00fanea Paolucci","family":"de Paiva Silvino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinthia Elim","family":"Jannes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio Teruo","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella Ramos","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u00eada de F\u00e1tima Oliveira","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Costa","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6870-2063","authenticated-orcid":false,"given":"Karina Braga","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"6014_CR1","first-page":"13","volume":"9","author":"AG Moltuski","year":"1989","unstructured":"Moltuski AG (1989) Genetic Familial Hypercholesterolemia and its diagnosis. Atherosclerosis 9:13\u201317","journal-title":"Atherosclerosis"},{"key":"6014_CR2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0929-6646(08)60044-3","volume":"106","author":"KC Yang","year":"2007","unstructured":"Yang KC, Su YN, Shew JY, Yang KY, Tseng WK, Wu CC, LEE YT, (2007) LDLR and ApoB are major genetic causes of autosomal dominant hypercholesterolemia in a Taiwanese population. J Formos Med Assoc 106:799\u2013807","journal-title":"J Formos Med Assoc"},{"key":"6014_CR3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","volume":"34","author":"M Abifadel","year":"2003","unstructured":"Abifadel M, Varret M, Rab\u00e8s JP et al (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34:154\u2013156","journal-title":"Nat Genet"},{"key":"6014_CR4","first-page":"35","volume":"14","author":"S Nitika","year":"2019","unstructured":"Nitika S, Movva S, Balakrishnan P, Biji IK, Sawhney JPS, Puri R, Arora A, Saxena R, Mishra S, Apte S, Kulshrestha S et al (2019) Genetic analysis of familial hypercholesterolemia in Asian Indians a single center study. J Clin Lipidol 14:35\u201345","journal-title":"J Clin Lipidol"},{"key":"6014_CR5","first-page":"75","volume":"64","author":"FA Al-Allaf","year":"2017","unstructured":"Al-Allaf FA, Abduljaleel AAZ, Taher MM, Bouazzaoui A, Abalkhail H, Athar AFAM (2017) Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient. ABP 64:75\u201379","journal-title":"ABP"},{"issue":"4","key":"6014_CR6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmedgenet-2016-104054","volume":"54","author":"S Leigh","year":"2017","unstructured":"Leigh S, Futema M, Whittall R, Taylor-Beadling A, Williams M, Dunnen JT, Humphries SE (2017) The UCL low-density lipoprotein receptor gene variant database: pathogenicity update. J Med Genet 54(4):217\u2013233","journal-title":"J Med Genet"},{"key":"6014_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3949\/ccjm.87a.19021","volume":"87","author":"NP Shah","year":"2020","unstructured":"Shah NP et al (2020) Familial hypercholesterolemia: Detect, treat, and ask about family. Cleve Clin J Med 87:109\u2013120","journal-title":"Cleve Clin J Med"},{"key":"6014_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","volume":"72","author":"RR Williams","year":"1993","unstructured":"Williams RR, Hunt SC, Schumacher MC et al (1993) Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol 72:171\u2013176","journal-title":"Am J Cardiol"},{"key":"6014_CR9","unstructured":"World Health Organization Familial Hypercholesterolaemia (FH): Report of a Second WHO Consultation (1999) World Health Organization, Geneva (World Health Organization)"},{"key":"6014_CR10","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE et al (2013) Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. Eur Heart J 34:3478\u20133490","journal-title":"Eur Heart J"},{"key":"6014_CR11","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera AV, Chaffin M, Aragam KG et al (2018) Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 50:1219\u20131224","journal-title":"Nat Genet"},{"key":"6014_CR12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s004390050243","volume":"98","author":"K Steyn","year":"1996","unstructured":"Steyn K, Goldberg YP, Kotze MJ, Steyn M, Swanepoel AS, Fourie JM, Coetzee GA, Van Der Westhuyzen DR (1996) Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations. Hum Genet 98:479\u2013484","journal-title":"Hum Genet"},{"key":"6014_CR13","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/eurheartj\/ehx136","volume":"38","author":"BG Nordestgaard","year":"2017","unstructured":"Nordestgaard BG, Benn M (2017) (2017) Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world? Eur Heart J 38:1580\u20131583","journal-title":"Eur Heart J"},{"key":"6014_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.atherosclerosis.2018.08.021","volume":"277","author":"PH Harada","year":"2018","unstructured":"Harada PH, Miname MH, Bense\u00f1ora IM, Santos RD, Lotufo PA (2018) Familial hypercholesterolemia prevalence in an admixed racial society: Sex and race matter.The ELSA-Brasil. Atherosclerosis 277:273\u2013277. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.08.021","journal-title":"Atherosclerosis"},{"key":"6014_CR15","doi-asserted-by":"crossref","unstructured":"Benito-Vicente A, Uribe K, Jebari S, Galicia-Garcia U, Ostolaza H, Martin C (2018) Familial hypercholesterolemia: the mos frequent cholesterol metabolism disorder caused disease. Int J MolSci 19:1\u201321 pii:E3426","DOI":"10.3390\/ijms19113426"},{"key":"6014_CR16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","volume":"4","author":"RD Santos","year":"2016","unstructured":"Santos RD, Gidding SS, Hegele RA et al (2016) International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. Definingsevere familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. Lancet Diabetes Endocrinol 4:850\u2013861","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6014_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.a2423","volume":"337","author":"J Versmissen","year":"2008","unstructured":"Versmissen J et al (2008) Efficacy of statins in familial hypercholesterolaemia a long term cohort study. BMJ 337:1\u20136","journal-title":"BMJ"},{"key":"6014_CR18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RIF (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifugue. Clin Chem 18:499\u2013552","journal-title":"Clin Chem"},{"key":"6014_CR19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/VHRM.S49840","volume":"9","author":"JM Foody","year":"2013","unstructured":"Foody JM et al (2013) Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy. Vasc Health Risk Manag 9:719\u2013727","journal-title":"Vasc Health Risk Manag"},{"key":"6014_CR20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2013.10.022","volume":"232","author":"CM Ballantyne","year":"2014","unstructured":"Ballantyne CM et al (2014) Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high risk patients: results of the GRAVITY randomized study. Atherosclerosis 232:86\u201393","journal-title":"Atherosclerosis"},{"key":"6014_CR21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/humu.9032","volume":"19","author":"LA Salazar","year":"2002","unstructured":"Salazar LA, Hirata MH, CavalliSA NER, Forti N, Jaime Diament J, Giannini SD, Bertolami MC, Hirata RDC (2002) Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations. Hum Mutat 19:462\u2013463","journal-title":"Hum Mutat"},{"key":"6014_CR22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2014.11.009","volume":"238","author":"CE Jannes","year":"2015","unstructured":"Jannes CE, Dias RS, Silva PRS, Turolla L, Gagliardi ACM, Marsiglia JDC, Chacra AP, Miname MH, Rocha VZ, Salgado-Filho W, Krieger JE, Pereira AC (2015) Familialhypercholesterolemia in Brazil: cascadescreeningprogram, clinicalandgeneticaspects. Atherosclerosis 238:101\u2013107","journal-title":"Atherosclerosis"},{"key":"6014_CR23","first-page":"1","volume":"20","author":"A Garg","year":"2019","unstructured":"Garg A, Fazio S, Duell PB, Baass A, Udata C, Joh T, Riel T, Sirota M, Dettling D, Liang H, Garzone PD, Gumbiner B, Wan H (2019) Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort. J Endocr Soc 20:1\u201316","journal-title":"J Endocr Soc"},{"key":"6014_CR24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","volume":"133","author":"SD Ferranti","year":"2016","unstructured":"Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK, Sheldrick CR (2016) Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES). Circulation 133:1067\u20131072","journal-title":"Circulation"},{"key":"6014_CR25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/joim.12263","volume":"276","author":"C Maglio","year":"2014","unstructured":"Maglio C, Mancina RM, Motta BM et al (2014) Genetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing. J Intern Med 276:396\u2013403","journal-title":"J Intern Med"},{"key":"6014_CR26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2018.08.022","volume":"277","author":"Y Hsiung","year":"2018","unstructured":"Hsiung Y, Linb P, Chena C, Tungc Y, Yanga W, Chena L, Sub T (2018) Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan. Atherosclerosis 277:440\u2013447","journal-title":"Atherosclerosis"},{"key":"6014_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.arr.2014.12.001","volume":"19","author":"H Liu","year":"2015","unstructured":"Liu H, Li J (2015) Aging and dyslipidemia A review of potential mechanisms. Ageing Res Rev 19:43\u201352","journal-title":"Ageing Res Rev"},{"key":"6014_CR28","first-page":"119","volume":"110","author":"A De Lorenzo","year":"2018","unstructured":"De Lorenzo A, Silva JDL, Jannes CE, Pereira AC, Moreira ASB (2018) Anthropometric and Biochemical Characteristics of Patients with or without Genetically Confirmed Familial Hypercholesterolemia. Arq Bras Cardiol 110:119\u2013123","journal-title":"Arq Bras Cardiol"},{"key":"6014_CR29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.04.011","volume":"229","author":"M Futema","year":"2013","unstructured":"Futema M et al (2013) Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic. Atherosclerosis 229:161\u2013168","journal-title":"Atherosclerosis"},{"key":"6014_CR30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.atherosclerosis.2016.08.037","volume":"253","author":"T Grenkowitz","year":"2016","unstructured":"Grenkowitz T, Kassner U, W\u00fchle-Demuth M, Salewsky B, Rosada A, Zemojtel T, Hopfenm\u00fcller W, Isermann B, Borucki K et al (2016) Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia. Atherosclerosis 253:88\u201393","journal-title":"Atherosclerosis"},{"key":"6014_CR31","first-page":"15","volume":"3","author":"AM Medeiros","year":"2017","unstructured":"Medeiros AM, Alves AC, Chora JR, Bourbon M (2017) Portuguese familial hypercholesterolaemiastudy. Instituto_Nacional de Sa\u00fade Dr. Ricardo Jorge- Doen\u00e7as n\u00e3o-transmiss\u00edveis- artigos breves 3:15\u201318","journal-title":"Ricardo Jorge- Doen\u00e7as n\u00e3o-transmiss\u00edveis- artigos breves"},{"key":"6014_CR32","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/humu.23634","volume":"39","author":"MA Iacocca","year":"2018","unstructured":"Iacocca MA, Chora JR, Carrie A, Freiberger T, Leigh SE, Defesche JC et al (2018) ClinVardatabaseof global familial hypercholesterolemiaassociated DNA variants. Hum Mutat 39:1631\u20131640","journal-title":"Hum Mutat"},{"key":"6014_CR33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.atherosclerosis.2007.07.019","volume":"196","author":"M Bourbon","year":"2008","unstructured":"Bourbon M, Alves AC, Medeiros AM, Silva S, Soutar AK (2008) Familial hypercholesterolaemia in Portugal- Investigators of Portuguese FH Study. Atheroclerosis 196:633\u2013642","journal-title":"Atheroclerosis"},{"issue":"4701","key":"6014_CR34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.3873704","volume":"228","author":"TC S\u00fcdhof","year":"1985","unstructured":"S\u00fcdhof TC, Russell DW, Goldstein JL, Brown MS, Sanchez-Pescador R, Bell JI (1985) Cassette of eight exons shared by genes for LDL receptor and EGF precursor. Science 228(4701):893\u2013895","journal-title":"Science"},{"key":"6014_CR35","first-page":"131","volume":"11","author":"T Maruyama","year":"2004","unstructured":"Maruyama T, Yamashita S, Matsuzawa Y, Bujo H, Takahashi K, Saito Y et al (2004) Mutations in Japanese Subjects with Primary Hyperlipidemia - Results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996. J AtherosclerThromb 11:131\u2013145","journal-title":"J AtherosclerThromb"},{"key":"6014_CR36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(87)90079-1","volume":"48","author":"MA Lehrman","year":"1987","unstructured":"Lehrman MA, Goldstein JL, Russell DW, Brown MS (1987) Duplication of seven exons in LDL receptor gene caused by Alu-Alu recombination in a subject with familial hypercholesterolemia. Cell 48:827\u2013835","journal-title":"Cell"},{"key":"6014_CR37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.1380010602","volume":"1","author":"HH Hobbs","year":"1992","unstructured":"Hobbs HH, Brown MS, Goldstein JL (1992) Molecular Genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1:445\u2013466","journal-title":"Hum Mutat"},{"key":"6014_CR38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00109-005-0019-z","volume":"84","author":"SE Humphries","year":"2005","unstructured":"Humphries SE, Cranston T, Allen M, Middleton-Price H, Fernandez MC, Senior V (2005) Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing. J Molecular Medicine 84:203\u2013214","journal-title":"J Molecular Medicine"},{"key":"6014_CR39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10930-019-09860-5","volume":"38","author":"S Porntadavity","year":"2019","unstructured":"Porntadavity S, Jeenduang N (2019) Structure-Function Relationships of LDL Receptor Missense Mutations Using Homology Modeling. Protein J 38:447\u2013462","journal-title":"Protein J"},{"key":"6014_CR40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2017.151","volume":"20","author":"JR Chora","year":"2018","unstructured":"Chora JR, Medeiros AM, Alves AC, Bourbon M (2018) Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis. Genet Med 20:591\u2013598","journal-title":"Genet Med"},{"key":"6014_CR41","first-page":"1551","volume":"15","author":"J Cameron","year":"2006","unstructured":"Cameron J, Holla OL, Ranheim T, Kulseth MA et al (2006) Effect of mutations in the PCSK9 gene on the cell surface LDL receptors. HumMol Genet 15:1551\u20131558","journal-title":"HumMol Genet"},{"key":"6014_CR42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.atherosclerosis.2014.12.026","volume":"238","author":"A Benito-Vicente","year":"2015","unstructured":"Benito-Vicente A, Etxebarria A, Stef M, Ostolaza H, Palacios L, Martin C (2015) Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats. Atherosclerosis 238:304\u2013312","journal-title":"Atherosclerosis"},{"key":"6014_CR43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/humu.21630","volume":"33","author":"A Etxebarria","year":"2012","unstructured":"Etxebarria A, Palacios L, Stef M, Tejedor D, Uribe KB, Oleaga A, Irigoyen L, Torres B, Ostolaza H, Martin C (2012) Functional Characterization of Splicing and Ligand-Binding Domain Variants in the LDL Receptor. Hum Mutat 33:232\u2013243","journal-title":"Hum Mutat"},{"key":"6014_CR44","first-page":"15","volume":"1","author":"FH Resende","year":"2018","unstructured":"Resende FH (2018) \u2013 Bom Despacho 300 anos: Homens que constru\u00edram Tomo I: Dos prim\u00f3rdios do Arraial de Nossa Senhora do Bom Despacho (1715) \u00e0 emancipa\u00e7\u00e3o pol\u00edtico-administrativa (1912). Cap. II Velha Serrana- A s\u00e9tima vila do ouro da capitania de Minas Gerais 1:15\u201327","journal-title":"II Velha Serrana- A s\u00e9tima vila do ouro da capitania de Minas Gerais"},{"key":"6014_CR45","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/bmj.321.7275.1497","volume":"321","author":"D Bhatnagar","year":"2000","unstructured":"Bhatnagar D, Morgan J, Siddiq S et al (2000) Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia. Brit Med J 321:1497\u20131500","journal-title":"Brit Med J"},{"key":"6014_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm9010001","volume":"9","author":"RM Hendricks-Sturrup","year":"2019","unstructured":"Hendricks-Sturrup RM, Lu CY (2019) Understanding Implementation Challenges to Genetic Testing for Familial Hypercholesterolemia in the United States. J Pers Med 9:1\u20137","journal-title":"J Pers Med"},{"key":"6014_CR47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/clc.22881","volume":"41","author":"F S\u00e9guro","year":"2018","unstructured":"S\u00e9guro F, Rab\u00e8s J-P, Taraszkiewicz D, Ruidavets J-B, Bongard V, Ferri\u00e8res J (2018) Genetic diagnosis of familial hypercholesterolemia is associated with a premature and high coronary heart disease risk. Clin Cardiol 41:385\u2013391","journal-title":"Clin Cardiol"},{"key":"6014_CR48","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","volume":"67","author":"AV Khera","year":"2016","unstructured":"Khera AV, Won HH, Peloso GM et al (2016) Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J Am Coll Cardiol 67:2578\u20132589","journal-title":"J Am Coll Cardiol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06014-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-020-06014-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06014-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T10:30:57Z","timestamp":1607423457000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-020-06014-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6014"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-06014-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"14 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no conflict if interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Ethics Comitte of Federal University of Minas Gerais (CAAE- 76387417.6.0000.5149) and by the Ethics Comitte of the University of S\u00e3o Paulo (CAPPesqprotocol00594212.1001.0068). The project was carried out in accordance with the guidelines of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All subjects participating in the study and\/or their respective legal representatives were informed about the objectives and signed the Free and Informed Consent Form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}